Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Huang R, Jun DW, Toyoda H, Hsu YC, Trinh H, Nozaki A, Ishikawa T, Watanabe T, Uojima H, Huang DQ, Honda T, Tanaka Y, Vutien P, Marciano S, Abe H, Enomoto M, Atsukawa M, Takahashi H, Tsuji K, Takaguchi K, Tsai PC, Dai CY, Huang JF, Huang CF, Yeh ML, Yoon E, Kim SE, Ahn SB, Kim GA, Jung JH, Jeong SW, Oh H, Tseng CH, Ishigami M, Chau A, Maeda M, Yasuda S, Chuma M, Ito T, Kawashima K, Liu JK, Gadano A, Kozuka R, Itokawa N, Inoue K, Senoh T, Li J, Chuang WL, Cheung R, Wu C, Yu ML, Nguyen MH

Open source

DOI
10.3350/cmh.2024.1070
Published
2025 Jul
Container
Clinical and molecular hepatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3350/cmh.2024.1070,
  title = {Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.},
  author = {Huang R and Jun DW and Toyoda H and Hsu YC and Trinh H and Nozaki A and Ishikawa T and Watanabe T and Uojima H and Huang DQ and Honda T and Tanaka Y and Vutien P and Marciano S and Abe H and Enomoto M and Atsukawa M and Takahashi H and Tsuji K and Takaguchi K and Tsai PC and Dai CY and Huang JF and Huang CF and Yeh ML and Yoon E and Kim SE and Ahn SB and Kim GA and Jung JH and Jeong SW and Oh H and Tseng CH and Ishigami M and Chau A and Maeda M and Yasuda S and Chuma M and Ito T and Kawashima K and Liu JK and Gadano A and Kozuka R and Itokawa N and Inoue K and Senoh T and Li J and Chuang WL and Cheung R and Wu C and Yu ML and Nguyen MH},
  year = {2025},
  journal = {Clinical and molecular hepatology},
  doi = {10.3350/cmh.2024.1070},
  url = {https://doi.org/10.3350/cmh.2024.1070}
}

RIS

TY  - JOUR
TI  - Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.
AU  - Huang R
AU  - Jun DW
AU  - Toyoda H
AU  - Hsu YC
AU  - Trinh H
AU  - Nozaki A
AU  - Ishikawa T
AU  - Watanabe T
AU  - Uojima H
AU  - Huang DQ
AU  - Honda T
AU  - Tanaka Y
AU  - Vutien P
AU  - Marciano S
AU  - Abe H
AU  - Enomoto M
AU  - Atsukawa M
AU  - Takahashi H
AU  - Tsuji K
AU  - Takaguchi K
AU  - Tsai PC
AU  - Dai CY
AU  - Huang JF
AU  - Huang CF
AU  - Yeh ML
AU  - Yoon E
AU  - Kim SE
AU  - Ahn SB
AU  - Kim GA
AU  - Jung JH
AU  - Jeong SW
AU  - Oh H
AU  - Tseng CH
AU  - Ishigami M
AU  - Chau A
AU  - Maeda M
AU  - Yasuda S
AU  - Chuma M
AU  - Ito T
AU  - Kawashima K
AU  - Liu JK
AU  - Gadano A
AU  - Kozuka R
AU  - Itokawa N
AU  - Inoue K
AU  - Senoh T
AU  - Li J
AU  - Chuang WL
AU  - Cheung R
AU  - Wu C
AU  - Yu ML
AU  - Nguyen MH
PY  - 2025
JO  - Clinical and molecular hepatology
DO  - 10.3350/cmh.2024.1070
UR  - https://doi.org/10.3350/cmh.2024.1070
ER  -

APA

R, H., DW, J., H, T., YC, H., H, T., A, N., T, I., T, W., H, U., DQ, H., T, H., Y, T., P, V., S, M., H, A., M, E., M, A., H, T., K, T., K, T., PC, T., CY, D., JF, H., CF, H., ML, Y., E, Y., SE, K., SB, A., GA, K., JH, J., SW, J., H, O., CH, T., M, I., A, C., M, M., S, Y., M, C., T, I., K, K., JK, L., A, G., R, K., N, I., K, I., T, S., J, L., WL, C., R, C., C, W., ML, Y., & MH, N. (2025). Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.. Clinical and molecular hepatology. https://doi.org/10.3350/cmh.2024.1070

Source records